Navigation Links
Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre
Date:5/20/2008

ing Statements

Certain of the statements contained in this news release are forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown. Some examples of known risks are: the impact of general economic conditions, general conditions in the biotech industry, changes in the regulatory environment in the jurisdictions in which Haemacure does business, stock market volatility, fluctuations in costs, and changes to the competitive environment due to consolidation or otherwise. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. Haemacure disclaims any intention or obligation to update these statements.


'/>"/>
SOURCE Haemacure Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Haemacure Reports Third Quarter 2007 Results
2. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
3. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
4. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
5. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
6. Haemacure Reports on its annual general and special meeting of shareholders
7. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
8. Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008
9. Haemacure financing receives shareholder consent - Series B Warrants are amended
10. Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
11. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Indosoft, developer of the Q-Suite call center ... development of their 5.x line. The industry leading contact ... around the world for more than a decade. By announcing ... platform, Q-Suite can fully embrace newer Asterisk features and improve ... on Asterisk for more than a decade. The use of ...
(Date:3/31/2015)... Phoenix, AZ (PRWEB) March 31, 2015 The ... on the GMO controversy , just kicked off their ... oft-controversial term “substantial equivalence.” , “ Substantial Equivalence was ... United States,” states Eric Battersby, Director at Change The World ... to a point well before GMOs even entered our food ...
(Date:3/31/2015)... Plains, NJ (PRWEB) March 31, 2015 Dr. ... Institute for Advanced Reconstruction. He was recently quoted in ... is caused by lymphatic issues, causing fluid retention and tissue ... the procedure to relieve and / or improve lymphedema symptoms. ... to improve or alleviate the symptoms of lymphedema. The ...
(Date:3/31/2015)... March 31, 2015 Researchers at ... mice and humans: how human livers heal. The ... activates liver regeneration. Normally, mouse PPARa is far ... allowing mice to quickly regenerate damaged livers. However, ... 21 (FGF21) can boost the regenerative effects of ...
(Date:3/31/2015)... Indosoft, Inc., developers of contact center software ... SIP over TCP configuration for all SIP devices in Q-Suite ... contact center ACD (Automatic Call Distributor) system on ... TCP support to all SIP devices gives users an additional ... Voice over IP (VoIP) has primarily involved User Datagram Protocol ...
Breaking Medicine News(10 mins):Health News:Indosoft Announces End of Life for Asterisk 1.4 Support in Q-Suite 5 Call Center Software 2Health News:The Walk a Mile Project Launches New Research Sequence on Substantial Equivalence of GMOs 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 3Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 4Health News:Indosoft extends SIP over TCP support to User Extensions in its Q-Suite 5.9 Call Center Software 2
... addressed more aggressively, study says , , THURSDAY, May 22 ... lung function faster and more significantly as they age, ... age, according to new research. , Contrary to ... a restrictive rather than obstructive or asthma-like pattern. ...
... 22, 2008) - What common oral condition appears as ... Americans, can be caused by food allergies and hormonal ... Commonly referred to as canker sores, recurrent aphthous ulcers ... licorice root herbal extract, according to a study published ...
... exchanging a tooth for that coveted reward from the tooth ... happens when a primary or permanent tooth is lost prematurely ... March/April 2008 issue of General Dentistry, the AGDs clinical, peer-reviewed ... know what to do with a traumatically affected tooth and ...
... New Rochelle, NY, May 22, 2008 The Home ... to a $5.6 billion level and will continue to ... next three to five years, according to a new ... Ann Liebert company. Insight and Intelligence interviewed industry leaders, ...
... May 22 Medtronic Spine LLC, the,corporate successor ... United States $75,million to settle allegations that it ... Justice Department announced today. The government alleged,that Kyphon ... kyphoplasty,procedure, which is a minimally-invasive surgery used to ...
... 22 The California,Senate rejected a bill today sponsored ... its name after privacy violations. See Washington Post,coverage below., ... a second chance to pass,the Senate and will be ... in,existing law which bars the sharing of private medical ...
Cached Medicine News:Health News:Lung Trouble Associated With Sickle Cell in Kids 2Health News:Licorice extract provides new treatment option for canker sores 2Health News:Premature tooth loss can affect oral health for years to come 2Health News:Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations Of Defrauding Medicare 2Health News:Sponsor of Drug Bill Rejected by CA Senate Today Changed Its Name After Privacy Violations 2Health News:Sponsor of Drug Bill Rejected by CA Senate Today Changed Its Name After Privacy Violations 3
(Date:3/31/2015)... , March 31, 2015  InMed Pharmaceuticals ... stage biopharmaceutical company that specializes in developing safer, ... of Paul C. Anderson , Ph.D., to ... pharma industry veteran who brings significant drug discovery ... Anderson is a synthetic organic chemist by training ...
(Date:3/31/2015)... -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) ... and 300mg oral tablets, indicated for use in the ... Propafenone Hydrochloride 150mg, 225mg and 300mg tablets was $14 ... Arthur S. Przybyl , President and Chief Executive Officer ... our fourth product from the portfolio of approved generic ...
(Date:3/31/2015)... March 31, 2015  Oxis International, Inc. (OXIS) (OXI.PA) ... and commercialization, announced today Oxis CEO Tony Cataldo ... Oxis common shares on the Euronext exchange. Oxis shares ... symbol OXIS.   Oxis Chairman and CEO ... move forward with its strategies launched in 2014 and ...
Breaking Medicine Technology:InMed Pharmaceuticals Strengthens Scientific Advisory Board 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 3InMed Pharmaceuticals Strengthens Scientific Advisory Board 4ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Oxis International Inc. Announces Request for Euronext Trading Suspension 2
... Oct. 7 Cleveland Clinic,s Top 10 Medical Innovations for ... therapies that are being developed to treat everything from deafness ... The list of breakthrough devices and therapies was selected by ... was unveiled during Cleveland Clinic,s 2009 Medical Innovation ...
... Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) today ... offering of 3.97 million shares of its common stock to ... gross proceeds of $3.97 million. , The shares were ... with the Securities and Exchange Commission that was declared effective ...
Cached Medicine Technology:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 2Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 3Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 4Catalyst Pharmaceutical Partners, Inc. Announces the Closing of $3.97 Million Registered Direct Offering 2
Instrument set for carpal tunnel release....
Standard arthroscopy graspers for small joints. Also available are Mosquito Tip Graspers, 45 degree Forceps, SquareTrimmer Blunt Tip Forceps and SST Scoop Tip Forceps....
... SR™ Hand Implant System utilizes the same ... joint replacements. The SR™ Hand Implant ... other prostheses including minimal bone resection, surface ... articular surfaces, retention and/or repositioning of the ...
The efficient choice for small joint replacement technology -- the Ascension Silicone MCP features a similar design to our PyroCarbon MCP and utilizes the same instrumentation for intra-operative fle...
Medicine Products: